Cargando…

Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches

Heat shock protein 90 (Hsp90) is a molecular chaperone that plays an important role in tumour biology by promoting the stabilisation and activity of oncogenic ‘client’ proteins. Inhibition of Hsp90 by small-molecule drugs, acting via its ATP hydrolysis site, has shown promise as a molecularly target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Darby, John F., Vidler, Lewis R., Simpson, Peter J., Al-Lazikani, Bissan, Matthews, Stephen J., Sharp, Swee Y., Pearl, Laurence H., Hoelder, Swen, Workman, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524759/ https://www.ncbi.nlm.nih.gov/pubmed/32994435 http://dx.doi.org/10.1038/s41598-020-71969-w

Ejemplares similares

Distinctive Behaviors of Druggable Proteins in Cellular Networks
por: Mitsopoulos, Costas, et al.
Publicado: (2015)

Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites
por: Vidler, Lewis R., et al.
Publicado: (2012)

In silico identification and biochemical characterization of the human dicarboxylate clamp TPR protein interaction network
por: Bernadotte, Alexandra, et al.
Publicado: (2018)

Blocking the survival of the nastiest by HSP90 inhibition
por: Workman, Paul, et al.
Publicado: (2016)

Discovery of small molecule cancer drugs: Successes, challenges and opportunities
por: Hoelder, Swen, et al.
Publicado: (2012)

SiGNet: A signaling network data simulator to enable signaling network inference
por: Coker, Elizabeth A., et al.
Publicado: (2017)

Polypharmacology in Precision Oncology: Current Applications and Future  Prospects
por: Antolin, Albert A., et al.
Publicado: (2016)

Chaperone ligand-discrimination by the TPR-domain protein Tah1
por: Millson, Stefan H., et al.
Publicado: (2008)

Evolution of kinase polypharmacology across HSP90 drug discovery
por: Antolin, Albert A., et al.
Publicado: (2021)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
por: Hassan, Syed S., et al.
Publicado: (2018)

Objective, Quantitative, Data-Driven Assessment of Chemical Probes
por: Antolin, Albert A., et al.
Publicado: (2018)

The kinase polypharmacology landscape of clinical PARP inhibitors
por: Antolin, Albert A., et al.
Publicado: (2020)

Regulation of autophagy by nucleoporin Tpr
por: Funasaka, Tatsuyoshi, et al.
Publicado: (2012)

Localization of Nucleoporin Tpr to the Nuclear Pore Complex Is Essential for Tpr Mediated Regulation of the Export of Unspliced RNA
por: Rajanala, Kalpana, et al.
Publicado: (2012)

In silico work flow for scaffold hopping in Leishmania
por: Waugh, Barnali, et al.
Publicado: (2014)

The applications of deep learning algorithms on in silico druggable proteins identification
por: Yu, Lezheng, et al.
Publicado: (2022)

Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein–Protein Interactions?
por: Dias, David M., et al.
Publicado: (2013)

Structure‐Enabled Discovery of a Stapled Peptide Inhibitor to Target the Oncogenic Transcriptional Repressor TLE1
por: McGrath, Sally, et al.
Publicado: (2017)

In Silico Insights towards the Identification of NLRP3 Druggable Hot Spots
por: Mekni, Nedra, et al.
Publicado: (2019)

Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening
por: Vidler, Lewis R., et al.
Publicado: (2013)

B-Cell Epitope Mapping of TprC and TprD Variants of Treponema pallidum Subspecies Informs Vaccine Development for Human Treponematoses
por: Molini, Barbara, et al.
Publicado: (2022)

In Silico Assessment of Potential Druggable Pockets on the Surface of α(1)-Antitrypsin Conformers
por: Patschull, Anathe O. M., et al.
Publicado: (2012)

The Interaction of CRM1 and the Nuclear Pore Protein Tpr
por: Zhao, Charles L., et al.
Publicado: (2014)

Identification and Functional Analysis of Tomato TPR Gene Family
por: Zhou, Xi’nan, et al.
Publicado: (2021)

Nitazoxanide Inhibits the Bifunctional Enzyme GlG6PD::6PGL of Giardia lamblia: Biochemical and In Silico Characterization of a New Druggable Target
por: Martínez-Rosas, Víctor, et al.
Publicado: (2023)

The Four Canonical TPR Subunits of Human APC/C Form Related Homo-Dimeric Structures and Stack in Parallel to Form a TPR Suprahelix()
por: Zhang, Ziguo, et al.
Publicado: (2013)

Targeting the cryptic sites: NMR-based strategy to improve protein druggability by controlling the conformational equilibrium
por: Mizukoshi, Yumiko, et al.
Publicado: (2020)

In silico Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization
por: Michel, Maurice, et al.
Publicado: (2020)

In Silico Identification of Potential Druggable Binding Sites on CIN85 SH3 Domain
por: Vittorio, Serena, et al.
Publicado: (2021)

Rational design of non-resistant targeted cancer therapies
por: Martínez-Jiménez, Francisco, et al.
Publicado: (2017)

Structural insights into the regulation of Cas7-11 by TPR-CHAT
por: Ekundayo, Babatunde, et al.
Publicado: (2022)

Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition
por: Morgan, Rhodri M. L., et al.
Publicado: (2012)

The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use
por: Antolin, Albert A, et al.
Publicado: (2022)

The Effect of Mutations in the TPR and Ankyrin Families of Alpha Solenoid Repeat Proteins
por: Izert, Matylda Anna, et al.
Publicado: (2021)

The PTPIP51 TPR-Domain: A Novel Lipid Transfer Domain?
por: Giordano, Francesca, et al.
Publicado: (2021)

canSAR: an integrated cancer public translational research and drug discovery resource
por: Halling-Brown, Mark D., et al.
Publicado: (2012)

canSAR: updated cancer research and drug discovery knowledgebase
por: Bulusu, Krishna C., et al.
Publicado: (2014)

canSAR chemistry registration and standardization pipeline
por: Dolciami, Daniela, et al.
Publicado: (2022)

In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets
por: Ricci, Federico, et al.
Publicado: (2022)

KRAS: Druggable at Last
por: Herzberg, Benjamin O, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m79o412p1rtp0rpgi0ugh2f18u